Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove Guidelines or Manual
- Remove Advisory
- Remove Nicotine
- Remove Cocaine
- Remove Methadone
- Remove Oxycodone
- Remove Pain Relievers
- Remove Dextromethorphan
- Remove Treatment
- Remove Medication-Assisted Treatment
- Remove Naltrexone
- Remove Prevention
- Remove Education
- Remove Nicotine Replacement Therapy
- Remove Psychosocial Rehabilitation
Main page content
Published: October 2021This updated TIP reviews what is known about treating the medical, psychiatric, and SUD-related problems associated with the use of cocaine and methamphetamine, as well as the misuse of prescription stimulants. The TIP offers recommendations on treatment approaches and maximizing treatment engagement and retention, and strategies for initiating and maintaining abstinence.
Published: August 2021The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Published: July 2021This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Published: August 2018This quick guide contains an overview of the challenges associated with tobacco cessation and the benefits of being tobacco-free for individuals as well as those of a smoke-free workplace. It also includes tips that substance use disorder treatment settings can use to implement their own tobacco cessation programs.